← All Zyversa Therapeutics, INC filings

Zyversa Therapeutics, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

OQB
ZVSA
Zyversa Therapeutics, INC
SCHEDULE: Armistice Capital Reduces Stake in ZyVersa Therapeutics
Armistice Capital, LLC reports a decreased ownership stake in ZyVersa Therapeutics, Inc., falling below the 5% threshold.
OQB
ZVSA
Zyversa Therapeutics, INC
SCHEDULE 13G: Armistice Capital Discloses Nearly 10% Passive Stake in ZyVersa Therapeutics
Armistice Capital, LLC and Steven Boyd have filed a Schedule 13G, revealing a 9.99% passive ownership stake in ZyVersa Therapeutics, Inc.